063160 종근당바이오
기본 정보
- 섹터: KOSPI:제약
- 시가총액: 721억원 (2026-06-30 기준)
- 첫 등장: 2026-06-29 (누적 1일)
- 태그: 매크로/바이오헬스 · 원료의약품 · 발효 · 프로바이오틱스 · 마이크로바이옴 · CDMO · 보툴리눔톡신
- 네이버 금융: 🔗
기업개요
- 동사는 2001년 ㈜종근당으로부터 분할 설립된 발효·바이오 전문기업으로, 항생제, 당뇨병치료제, 면역억제제 등 원료의약품과 프로바이오틱스를 생산함.
- 2021년 마이크로바이옴 전용 GMP 설비를 구축해 CDMO 체계를 갖추었고, 2025년 보툴리눔 톡신 국내 품목허가를 획득해 시장에 진출함.
- 50년 이상 축적된 기술 기반으로 FDA 등 글로벌 인증 보유, 세계 40여 개국에 제품 공급하며, 지속 가능한 성장 기반을 구축하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | 13,220 | 12,810 | 🔵 -3.10% | — | ×2.9 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | +0.0 | +0.0 | -0.5 | +0.0 |
| 2026-07-13 | 13,380 | 13,220 | 🔵 -1.20% | — | ×0.3 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-10 | 12,880 | 13,380 | 🔴 +3.88% | — | ×0.1 | 🟢 외인 | +0.6억 | +0.6 | +0.0 | +0.0 | +0.0 | -0.6 | +0.0 |
| 2026-07-09 | 13,370 | 12,880 | 🔵 -3.66% | — | ×0.1 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | +0.0 | +0.0 | +0.1 | +0.0 |
| 2026-07-08 | 13,710 | 13,370 | 🔵 -2.48% | — | ×0.0 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | +0.0 |
| 2026-07-07 | 13,610 | 13,710 | 🔴 +0.73% | — | ×0.1 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-07-06 | 13,510 | 13,610 | 🔴 +0.74% | — | ×0.0 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-03 | 13,590 | 13,510 | 🔵 -0.59% | — | ×0.0 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | -0.0 | -0.0 | -0.1 | -0.0 |
| 2026-07-02 | 13,590 | 13,590 | ⚪ +0.00% | — | ×0.0 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-01 | 13,150 | 13,590 | 🔴 +3.35% | — | ×0.1 | 🟢 외인 | +0.0억 | +0.0 | +0.0 | +0.0 | +0.0 | -0.0 | +0.0 |
| 2026-06-30 | 13,710 | 13,150 | 🔵 -4.08% | — | ×0.1 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.2 | +0.0 |
| 2026-06-29 | 12,430 | 13,710 | 🔴 +10.30% | — | ×0.1 | 🟢 외인 | +1.4억 | +1.4 | +0.0 | +0.0 | +0.0 | -1.4 | +0.0 |
| 2026-06-26 | 12,900 | 12,430 | 🔵 -3.64% | — | ×0.1 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | +0.2 | +0.0 |
| 2026-06-25 | 13,320 | 12,900 | 🔵 -3.15% | — | ×0.1 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | -0.0 | +0.0 | +0.4 | +0.0 |
| 2026-06-24 | 13,390 | 13,320 | 🔵 -0.52% | — | ×0.2 | 🟢 외인 | +1.3억 | +1.3 | +0.0 | +0.0 | +0.0 | -1.5 | +0.1 |
| 2026-06-23 | 14,500 | 13,390 | 🔵 -7.66% | — | ×0.3 | 🟢 외인 | +2.5억 | +2.5 | -0.0 | +0.0 | -2.5 | +0.0 | |
| 2026-06-22 | 15,340 | 14,500 | 🔵 -5.48% | — | ×0.4 | 🟢 외인 | +1.1억 | +1.1 | -0.0 | +0.0 | -1.2 | +0.1 | |
| 2026-06-19 | 15,990 | 15,340 | 🔵 -4.07% | — | ×3.8 | 🔻 개인 | -2.4억 | -2.1 | -0.4 | -0.0 | +2.5 | -0.0 | |
| 2026-06-18 | 16,170 | 15,990 | 🔵 -1.11% | — | ×186.8 | 🔻 개인 | -1.8억 | -1.4 | -0.4 | +0.0 | +1.7 | +0.1 | |
| 2026-06-17 | 16,020 | 16,170 | 🔴 +0.94% | — | ×0.7 | 🟢 외인 | +0.1억 | +0.4 | -0.3 | -0.2 | +0.1 | +0.0 | |
| 2026-06-16 | 15,910 | 16,020 | 🔴 +0.69% | — | ×0.3 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | |
| 2026-06-15 | 15,950 | 15,910 | 🔵 -0.25% | — | ×0.3 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | +0.0 | |
| 2026-06-12 | 15,590 | 15,950 | 🔴 +2.31% | — | ×0.8 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | -0.3 | +0.0 | |
| 2026-06-11 | 15,450 | 15,590 | 🔴 +0.91% | — | ×0.5 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | +0.0 | -0.4 | +0.0 | |
| 2026-06-10 | 15,590 | 15,450 | 🔵 -0.90% | — | ×0.5 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 | |
| 2026-06-09 | 15,200 | 15,590 | 🔴 +2.57% | — | ×0.9 | 🟢 외인 | +0.4억 | +0.4 | +0.0 | +0.0 | -0.4 | +0.0 | |
| 2026-06-08 | 15,960 | 15,200 | 🔵 -4.76% | — | ×1.0 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 | |
| 2026-06-05 | 16,160 | 15,960 | 🔵 -1.24% | — | ×0.4 | 🔻 개인 | -0.0억 | -0.0 | +0.0 | +0.0 | +0.0 | +0.0 | |
| 2026-06-04 | 16,180 | 16,160 | 🔵 -0.12% | — | ×0.5 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.1 | +0.1 | |
| 2026-06-02 | 16,260 | 16,180 | 🔵 -0.49% | — | ×0.6 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | -0.3 | +0.0 | |
| 2026-06-01 | 16,950 | 16,260 | 🔵 -4.07% | — | ×1.7 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.5 | +0.0 | |
| 2026-05-29 | 17,640 | 16,950 | 🔵 -3.91% | — | ×1.7 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.2 | +0.0 | |
| 2026-05-28 | 17,800 | 17,640 | 🔵 -0.90% | — | ×1.2 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.4 | -0.0 | |
| 2026-05-27 | 17,930 | 17,800 | 🔵 -0.73% | — | ×0.8 | 🔻 개인 | -0.1억 | -0.1 | +0.0 | -0.0 | +0.1 | +0.0 | |
| 2026-05-26 | 17,940 | 17,930 | 🔵 -0.06% | — | ×0.3 | 🔻 개인 | -0.3억 | -0.3 | +0.0 | +0.0 | +0.3 | -0.0 | |
| 2026-05-22 | 17,650 | 17,940 | 🔴 +1.64% | — | ×0.7 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.1 | +0.0 |
일자별 사유 (최신 위)
2026-06-29
- 사유: —
- 섹터 컨텍스트: KOSPI:제약 (smart +895억)
- 매크로 원인: 반도체 쏠림 차익실현 후 제약·바이오로 순환매 유입 + 국민성장펀드 기대·바이오USA 훈풍에 동반 급등 (보통)